IQLT - ETF AI Analysis
Top Page
iShares MSCI Intl Quality Factor ETF (IQLT)
Rating:69Neutral
Price Target:―
Positive Factors
Strong Top Holding Performance
The largest position, ASML, along with several other major holdings like ABB, Advantest, and Shell, have shown strong gains, helping drive the ETF’s overall results.
Broad International Diversification
The fund spreads its investments across many countries including the UK, Japan, the U.S., Switzerland, and others, which helps reduce the impact of problems in any single market.
Solid Recent Performance and Large Asset Base
The ETF has delivered steady gains so far this year and manages a large pool of assets, suggesting it is an established and widely used fund.
Negative Factors
Meaningful Single-Stock Concentration
ASML makes up a noticeable share of the portfolio, so any sharp drop in this one stock could have an outsized effect on the ETF.
Mixed Results Among Top Holdings
Some key positions, such as AstraZeneca and Zurich Insurance Group, have been weak recently, which can offset the gains from stronger stocks.
Moderate Expense Ratio
The fund’s fee is not extremely high but is also not among the very cheapest, which slightly reduces the net return investors keep over time.
IQLT vs. SPDR S&P 500 ETF (SPY)
AUM13.83B
RegionDeveloped Markets
Expense Ratio0.30%
Beta0.73
IssueriShares
Inception DateJan 13, 2015
Dividend Yield2.38%
Asset ClassEquity
Index TrackedWorld ex USA Sector Neutral Quality
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,619,400
30 Day Avg. Volume1,462,741
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
57.11Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering297
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IQLT Summary
IQLT is the iShares MSCI Intl Quality Factor ETF, which follows the MSCI World ex USA Sector Neutral Quality index. It invests in high-quality companies from developed countries outside the U.S., focusing on firms with steady profits and strong finances. Well-known holdings include ASML Holding, Nestlé, Novartis, and Shell. Investors might consider IQLT to diversify beyond the U.S. and seek long-term growth from solid international businesses. A key risk is that international stock prices can go up and down with global markets and currency movements, so your investment value may fluctuate.
How much will it cost me?The iShares MSCI Intl Quality Factor ETF (IQLT) has an expense ratio of 0.30%, which means you’ll pay $3 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it focuses on a specific strategy of selecting high-quality international stocks, which requires more specialized research and management.
What would affect this ETF?The iShares MSCI Intl Quality Factor ETF (IQLT) could benefit from continued global economic growth and increased demand for high-quality companies in developed markets outside the U.S., particularly in sectors like financials, technology, and healthcare. However, it may face challenges from rising interest rates, which could pressure profitability in certain sectors, and geopolitical risks or regulatory changes in key regions that could impact its top holdings like ASML, Shell, and Nestlé. Diversification across sectors and countries helps mitigate some risks but does not eliminate them entirely.
IQLT Top 10 Holdings
IQLT’s story is driven by a handful of international heavyweights, with ASML acting as the star performer over the year even if its recent momentum has cooled a bit. Financial powerhouses like Allianz and Zurich Insurance are steadily pulling their weight, while healthcare names Roche and Novartis add a healthy dose of resilience with rising share prices. On the flip side, Nestlé looks a bit sleepy and AstraZeneca is losing steam, modestly tugging on returns. Overall, the fund leans toward non-U.S. developed markets with a balanced mix of financials, industrials, and healthcare leaders.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 5.43% | $749.10M | €547.84B | 141.04% | 76 Outperform | |
| Allianz | 2.69% | $371.16M | €163.79B | 28.65% | 67 Neutral | |
| Roche Holding AG | 2.20% | $303.73M | $348.96B | 38.80% | 73 Outperform | |
| ABB Ltd | 1.96% | $269.73M | kr1.68T | 48.01% | 78 Outperform | |
| Zurich Insurance Group | 1.83% | $252.84M | CHF90.62B | 10.73% | 78 Outperform | |
| Nestlé SA | 1.81% | $250.18M | CHF208.38B | 13.38% | 71 Outperform | |
| Novartis AG | 1.79% | $246.82M | CHF231.75B | 34.41% | 80 Outperform | |
| AstraZeneca | 1.68% | $231.97M | $264.13B | 13.76% | 80 Outperform | |
| Advantest | 1.66% | $228.52M | ¥22.67T | 190.00% | 75 Outperform | |
| Shell (UK) | 1.59% | $219.74M | £187.43B | 24.99% | 73 Outperform |
IQLT Technical Analysis
Positive
―
Price Trends
49.08
Positive
48.06
Positive
46.68
Positive
Market Momentum
0.26
Negative
57.62
Neutral
70.37
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IQLT, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 49.58, equal to the 50-day MA of 49.08, and equal to the 200-day MA of 46.68, indicating a bullish trend. The MACD of 0.26 indicates Negative momentum. The RSI at 57.62 is Neutral, neither overbought nor oversold. The STOCH value of 70.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IQLT.
IQLT Peer Comparison
Comparison Results
Performance Comparison
IQLT
iShares MSCI Intl Quality Factor ETF
50.36
9.42
23.01%
VEA
Vanguard FTSE Developed Markets ETF
―
―
―
SCHF
Schwab International Equity ETF
―
―
―
SPDW
SPDR Portfolio Developed World ex-US ETF
―
―
―
IDEV
iShares Core MSCI International Developed Markets ETF
―
―
―
AVDE
Avantis International Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents